Organisation paid for research Program year 2025 Source: CMS Open Payments

Comprehensive Clinical Research

Neither a doctor nor a teaching hospital

Research payments

$560,268

38 payments

Through program year 2025, Comprehensive Clinical Research is reported as receiving $560,268 in research payments, across 38 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$80	1
2024	Research	$9,706	1
2023	Research	$41,015	11
2022	Research	$193,925	16
2021	Research	$199,612	8
2020	Research	$115,930	1

Breakdown

Who paid Research payments · program years 2020–2025

Gen-Probe, Inc. $278,750 15 payments
Merck Sharp & Dohme Corporation $116,991 8 payments
Cepheid $115,930 1 payment
Mylan Inc. $25,214 8 payments
Mylan Technologies Inc. $16,132 3 payments
OraSure Technologies Inc. $7,250 3 payments

Studies the money was for Research payments · program years 2020–2025

A10810-Atvps-Csp $209,874 9 payments
A Phase 3, Multicenter, Open-Label Study to Evaluate the Safety and Immunogenicity of 2-dose Regimens of 9vHPV and mRNA-1273 SARS-CoV-2 Vaccines Where the First Dose of Each Vaccine Are Given Concomitantly in Boys and Girls 9 to 11 Years of Age $116,912 7 payments
Xpert Xpress MVP Test $115,930 1 payment
A10940-SC2/FluP-CSP-02 $34,438 3 payments
A10960-Sc2p-Csp-01 / A10960-Sc2p-Csp-02 $34,438 3 payments
Mr-100A-01-Td-3001-A Phase 3, Multicenter, Open-Label, Single Arm Study of Mr-100A-01 in Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safety $25,214 8 payments
Phase 3, Multicenter, Open-Label, Single Arm Study of Mr-100A-01 in Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safety $16,132 3 payments
Sample Acquisition and Testing Protocol for Development of Tests to Detect Antigens to COVID-19 and Influenza A and B $4,250 1 payment
Clinical Sample Collection and Testing Protocol $3,000 2 payments
A Phase 3, Multicenter, Open-Label Study to Evaluate the Safety and Immunogenicity of 2-dose Regimens of 9vHPV and mRNA-1273 SARS-CoV-2 Vaccines Where the First Dose of Each Vaccine Are Given Concomitantly in Boys and Girls 9 to 11 Years of Age $80 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.